Impact of COVID-19 Anaylsis On I.V. Dressing Market Size, Hampering Growth 2021
Rising incidences of infections such as central line associated bloodstream infection (CLABSI), catheter-related bloodstream infection (CRBSI), and other infections are expected to boost growth of the I.V. dressing market over the forecast period. For instance, according to the data published in National Healthcare Safety Network Bloodstream Infection Surveillance in March 2018, around 30,000 CLABSI cases are reported every year in the U.S. CLABSI can prolong the hospital stay, which can increase the cost burden on patients and also may lead to mortality.
Apply Promo Code “STAYHOME” and Get Up to 30% Discount
Buy This Complete A Business Report:
Furthermore, according to the International Society for Infectious Diseases, March 2018, around 250,000 cases of blood stream are reported every year in the U.S. among these, around 80,000 are catheter-related bloodstream infection (CRBSI), which occurs in intensive care units.
North America accounted for the largest market share in 2018, owing to launches and approvals of new I.V. dressing products in the region. For instance, in January 2016, Entrotech life sciences, a U.S.-based company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ChloraDerm dressing, which protects against multi-drug-resistant organisms and other catheter-related bloodstream infections.
Moreover, in September 2016, Becton, Dickinson and Company and Vancive Medical Technologies entered into a collaboration to launch a line of ChloraShield I.V. dressings developed for vascular access dressing and enhancing patient care. Therefore, these factors are expected to boost growth of the global I.V. dressing market over the forecast period.
Key players operating in the global I.V. dressing market include Medline Industries, 3M, Paul Hartmann AG, Deroyal, Tytex Inc., Reliamed, Acelity, BSN Medical, CareFusion, Lohmann & Rauscher, Smith & Nephew, Shandong Dermcosy Medical Co.,Ltd., Talent Health Care, Datt Mediproducts Private Limited, and Others.
Moreover, key players in the market are focused on developing new products, in order to enhance their market share. For instance, in 2015, 3M launched Tegaderm CHG Chlorhexidine Gluconate I.V. port dressing for the patients with port devices under the skin, who are connected to catheter for central venous infusion.
Get PDF Brochure Of This Research Report @
Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact of COVID-19 Anaylsis On I.V. Dressing Market Size, Hampering Growth 2021 here
News-ID: 2246128 • Views: 130
More Releases from business news
Impact Covid-19 Analysis On Cleanroom Consumables Market is Booming Growth
Consumables for the cleanroom are very important, which are used for the maintenance of healthy and controlled environment and also enhances the safety and efficiency of in workflow of healthcare professionals and workers. Moreover, contamination of products can be avoided using consumables by the operator and staff working by covering hair, hand, and shoes. Cleanroom consumables such as cleanroom apparels, gloves are majorly used in the manufacturing companies such as
Impact Covid-19 Analysis On Swab Market in-Depth Analysis 2021
CMI announced that it’s published an exclusive report namely Global Swab Market by Manufacturers, Regions, Type, and Application, Forecast to 2027 in its research database with report summary, table of content, research methodologies, and data sources. The research study offers a substantial knowledge platform for entrants and investors as well as veteran companies, manufacturers functioning in the Worldwide Swab Market. This is an informative study covering the market with an
Impact Covid-19 Analysis On Sterile Injectables Market by Manufacturers to Expan …
Increasing product launches and product approvals by key players are the major factors that are expected to drive the global sterile injectables market growth over the forecast period. For instance, in September 2018, Dr Reddy’s Laboratories Ltd launched Neostigmine Methylsulfate Injection in the U.S., a generic version of the Bloxiverz (Neostigmine Methylsulfate) injection. Moreover, in July 2016, Claris Lifescience Ltd., a sterile injectables company received the Abbreviated New Drug Application
Impact of Covid-19 Analysis On Fall Detection Systems Market Strategies to Expan …
A fall detection system is a device that is used to alert emergency services in the event of a fall. Such devices have the potential to mitigate some of the adverse consequences of a fall. The global fall detection systems market is estimated to account for US$ 402.8 Mn in terms of value in 2019 and is expected to account for US$ 604.3 Mn by the end of 2027. Increasing geriatric population
More Releases for CLABSI
I.V. Dressing Market 2030 Emerging Trends and Global Demand During the COVID-19 …
Coherent Market Insights published a report, titled, "I.V. Dressing Market, by Product Type (Transparent and Translucent), by Use (Reusable and Disposable), by End User (Hospitals, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027." Rising incidences of infections such as central line associated bloodstream infection (CLABSI), catheter-related bloodstream infection (CRBSI), and other infections
Hospital-acquired Disease Testing Market Size and Growth, Current Analysis with …
Hospital acquired disease or nosocomial infection is a localized or systemic condition in patients which occurs due to adverse reaction caused by infectious toxin agents during medical care, and were absent at the time of admission. Hospital-acquired infections result in prolonged hospital stay, antimicrobial resistance, long-term disabilities, and higher mortality rate. Pathogens responsible for hospital-acquired diseases include viruses, fungal parasites, and bacteria. Hospital-acquired diseases also include catheter-related blood stream infections, surgical
Healthcare-Associated Gram-Negative Infections Epidemiology Scenario and Future …
Health care-associated infections (HAIs) are among the most common complications of hospital care, resulting in 1.7 million infections and 99,000 deaths each year. Infections caused by Gram-negative bacteria are of particular public health concern since they are at the root of approximately 30-70% of HAIs across the globe. Considering this fact, a study titled “EpiCast Report: Healthcare-Associated Gram-Negative Infections - Epidemiology Forecast to 2026” has been added to the massive
EpiCast Report: Healthcare-Associated Gram-Negative Infections - Epidemiology Fo …
"The Report EpiCast Report: Healthcare-Associated Gram-Negative Infections - Epidemiology Forecast to 2026 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" EpiCast Report: Healthcare-Associated Gram-Negative Infections - Epidemiology Forecast to 2026 Summary Healthcare-associated infections (HAIs) are a major threat to patient safety. HAIs occur in hospitalized patients, and are not present at the time of admission. Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1319636 The most
Healthcare-Associated Gram-Negative Infections - Epidemiology Forecast to 2026
"The Report EpiCast Report: Healthcare-Associated Gram-Negative Infections - Epidemiology Forecast to 2026 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Healthcare-associated infections (HAIs) are a major threat to patient safety. HAIs occur in hospitalized patients, and are not present at the time of admission. The most common types of HAIs are related to the use of invasive devices or surgical procedures, and
Pharmacy OneSource Announces Free Webinar on Pediatric Infection Prevention
Preventing Central Line-Associated Bloodstream Infections for Pediatric Patients Bellevue, Wash. – Wolters Kluwer Health announced today that Pharmacy OneSource, software-as-a-service provider of Sentri7, an infection prevention surveillance, documentation and reporting application, is hosting a complimentary webinar with Brenda Vason, RN, BSN, CIC on "CLABSI Prevention Strategies for the Pediatric Patient." Prevention of central line-associated bloodstream infection (CLABSI) in the pediatric population is unique and challenging. Vason will provide information on prevention